Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Nitro Blue Tetrazolium (NBT) is a chromogenic substrate that, like other tetrazolium compounds, can be reduced to produce a colored formazan derivative.1 It is used in the “NBT test” to evaluate the activity of NADPH oxidase in phagocytes, which results in the production of blue reduced NBT formazan in normal cells but not in those from patients with chronic granulomatous disease.2,3 NBT can also be used as a chromogenic activity stain for oxidoreductases in gels or solutions.4 More commonly NBT is often paired with 5-bromo-4-chloro-3-inolyl phosphate (PCIB) for the colorimetric detection of alkaline phosphatase activity.5 Alkaline phosphate converts PCIB to a product that reduces NBT to its formazan derivative, resulting in a black-purple precipitate.
WARNING This product is not for human or veterinary use.
1. Handbook of biological dyes and stains: Synthesis and industrial applications. (2010).
2. Technique for the performance of the nitro-
3. Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J. Clin. Invest. 48(10), 1895-1904 (1969).
4. NADH dehydrogenase from bovine neutrophil membranes. Purification and properties. The Journal of Biological Chemisty 261(1), 285-290 (1986).
5. Fluorescent in situ hybridization employing the conventional NBT/BCIP chromogenic stain. Biotechniques 42(6), 756-759 (2007).
Laboratory techniques in cellular and molecular medicine. (2021).